Eisai, BioTech Results from Real-World, Long-Term Treatment Persistence with LEQEMBI in the United States Presented at AD / PD 2026 23.03.2026 - 09:13:10 Real-World LEQEMBI Data Shows Patients Choose to Stay on Long-Term Treatment